Digipharms’ vision

Good Health is the greatest blessing of life. Life is a weary burden to a person of broken health. The richest man with bad health always suffers and groans. He is unhappy in spite of his great wealth.
In order to help to get a good health for people, we created Digipharm platform

• Digipharm aims to utilise innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivise innovation and expedite the transformation to personalised healthcare.
• Digipharms’ vision is to be ‘the pioneer of value-based healthcare delivery, innovative evidence generation and patient empowerment across the healthcare industry’ using revolutionary blockchain technology.

DPH health economy

The Digipharm platforms will be built to support all stakeholders seamlessly, utilising task automation via smart contracts wherever possible. It will be architected with security, data protection and regulatory compliance at the forefront of the design. The health economy will involve the following participants:

Patients

Patients are the focal point of the DPH health economy. Not only will patients receive the benefits of a value-based
healthcare approach, but if they so choose, they will be incentivised for contributing personal health related data to the Insights database for further use in health-related research.

Patients will:

• Provide permission to share data if they choose to participate
• Receive incentives to contributing their data in the form of access to valuable health information
• Potentially receive additional rewards and incentives in future once an appropriate mechanism is defined in compliance with regulatory and legal considerations

Payers

Payers are government entities or insurance providers that reimburse manufacturers companies or other stakeholders within the Digipharm health economy. Payers will:

• Participate in value-based pricing agreements
• Outline/Agree to value-based pricing agreements via the Reimburse user interface
• Potentially participate in automated payment mechanisms in the future, subject to
  regulatory and legal considerations
• Purchase access to the Insights database

Manufacturers

Manufacturers are pharmaceutical companies that produce and distribute treatments. Manufacturers will:

• Participate in innovative pricing agreements
• Outline/Agree to innovative pricing agreements via the Reimburse user interface
• Purchase access to the Insights database
• Potentially receive automated payments in future, subject to regulatory and legal considerations
  

  Providers

  
  Providers are hospital networks, clinicians, healthcare professionals etc. Providers will:
• Continue to measure and record clinical outcomes on existing local systems
• Not be required to individually enroll patients to Digipharm platforms
• Participate in personalised value-based pricing agreements directly with
  manufacturers (private healthcare)
• Potentially receive automated payments in the future (where applicable), subject
  to regulatory and legal considerations
• Potentially receive incentives from healthcare systems to ensure accurate and
  timely completion of outcomes data within patient records
• Purchase access to the Insights database

Platforms

Digipharms’ platforms are a decentralised public/private blockchain based solution that enables the delivery of valuebased pricing agreements to stakeholders and securely gathers and stores real world evidence from patient data. It enables the delivery of personalised healthcare solutions. Digipharm Platform Features:

• Smart contracts for innovative pricing agreements and task automation
• Patient website and app
• Interface for Manufacturers/Payers/Providers
• Integration into existing stakeholder I.T. infrastructure
• Legal/Regulatory/Compliance mechanisms

Digipharm tokens (DPH)

Digipharm (DPH) tokens will be used to pay license/access fees on Digipharm platforms. Access fees will invariably be determined and stipulated in USD value and the quantity of tokens required will depend on the type of access (manufacturer, patient, payer or provider) combined with the form of interaction required. The quantity of tokens required for such interactions is subject to change, relative to the market value of DPH.

Reimburse:

• Reimburse will eliminate the infrastructural barriers and automate the implementation of value based pricing agreements, no matter how complex, on a fully independent global platform; encouraging personalised reimbursement of health technology on a ‘fee for performance’ basis for the mutual benefit of patients, payers and manufacturers.
• Payers/manufacturers will be required to use DPH tokens to initiate or execute smart contracts within the Reimburse module and to enrol individual patients on these smart contracts, i.e. DPH tokens will be used to facilitate the process of annexing patients to innovative pricing and reimbursement agreements.

Insights:

DPH will be used as the utility token to power each interaction with the Insights database by healthcare stakeholders i.e.
DPH tokens will be used for access rights or specific data requests from the Insights platform.

DPH token sale Information

• DPH Supply: 100,000,000 Fixed (ERC-20)
• Ticker code: DPH
• Decimal Places: 18
• Token Price 1.00 USD
  

  DPH token sale Information Discount

  
  

Hurry up to join with us at
Website: https://www.digipharm.ch/
White paper: https://digipharm.ch/docs/DigipharmWP.pdf
Facebook: https://www.facebook.com/digipharmteam/
Twitter: https://twitter.com/DigipharmTeam
Telegram: https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ

My bitcointalk profile: https://bitcointalk.org/index.php?action=profile;u=1308037